Anthropic appointed Vas Narasimhan, CEO of Swiss pharmaceutical company Novartis, to its board of directors, the company's second new board addition in recent months following the addition of former Microsoft and General Motors executive Chris Liddell in February. The appointment comes as Anthropic deepens its enterprise push into healthcare, with existing partnerships with Eli Lilly, Novo Nordisk, and Genmab aimed at shortening drug development life cycles, and a recent acquisition of biotech startup Coefficient Bio. Anthropic is eyeing an IPO as soon as this year as its annualized revenue run rate has surpassed $30B.
Anthropic adds Novartis CEO Vas Narasimhan to its board as it expands into healthcare ahead of a potential IPO
Paul Drecksler is the founder and editor of Shopifreaks E-commerce Newsletter, covering the most important stories in e-commerce.
Never miss important e-commerce news
Our weekly newsletter is read religiously by 20,000+ e-commerce professionals.